Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
Comella P, Massidda B, Natale D, Putzu C, Sandomenico C, Filippelli G, Palmeri S, Condemi G, Vessia G, Barberis G, Ionta MT, Tafuto S, Barbato E. Comella P, et al. Clin Colorectal Cancer. 2011 Mar 1;10(1):42-7. doi: 10.3816/CCC.2011.n.006. Clin Colorectal Cancer. 2011. PMID: 21609935
A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.
Comella P, Gambardella A, Farris A, Maiorino L, Natale D, Massidda B, Casaretti R, Tafuto S, Lorusso V, Leo S; Southern Italy Cooperative Oncology Group. Comella P, et al. Crit Rev Oncol Hematol. 2005 Feb;53(2):133-9. doi: 10.1016/j.critrevonc.2004.10.008. Crit Rev Oncol Hematol. 2005. PMID: 15661564 Clinical Trial.
Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of two consecutive southern Italy cooperative oncology group trials.
Comella P, Massidda B, Filippelli G, Natale D, Farris A, Buzzi F, Tafuto S, Maiorino L, Palmeri S, De Lucia L, Mancarella S, Leo S, Roselli M, Lorusso V, De Cataldis G. Comella P, et al. Clin Colorectal Cancer. 2005 Sep;5(3):203-10. doi: 10.3816/ccc.2005.n.032. Clin Colorectal Cancer. 2005. PMID: 16197624 Clinical Trial.
Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial.
Comella P, Putzu C, Massidda B, Condemi G, De Cataldis G, Barbato E, Gambardella A, Avallone A, Franco L; Southern Italy Cooperative Oncology Group. Comella P, et al. Lung Cancer. 2007 May;56(2):263-71. doi: 10.1016/j.lungcan.2006.12.015. Epub 2007 Feb 12. Lung Cancer. 2007. PMID: 17298853 Clinical Trial.
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
Comella P, Massidda B, Filippelli G, Farris A, Natale D, Barberis G, Maiorino L, Palmeri S, Cannone M, Condemi G; Southern Italy Cooperative Oncology Group. Comella P, et al. J Cancer Res Clin Oncol. 2009 Feb;135(2):217-26. doi: 10.1007/s00432-008-0454-7. Epub 2008 Aug 22. J Cancer Res Clin Oncol. 2009. PMID: 18719941 Clinical Trial.
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group.
Comella P, Lorusso V, Maiorino L, Casaretti R, Cannone M, Massidda B, Putzu C, Leo S, Roselli M, Mancarella S, Palmeri S, Greco E, Vessia G, Sandomenico C, Franco L. Comella P, et al. Cancer Chemother Pharmacol. 2009 Oct;64(5):893-9. doi: 10.1007/s00280-009-0938-4. Epub 2009 Feb 3. Cancer Chemother Pharmacol. 2009. PMID: 19189106 Free article. Clinical Trial.
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial.
Comella P, Massidda B, Filippelli G, Palmeri S, Natale D, Farris A, De Vita F, Buzzi F, Tafuto S, Maiorino L, Mancarella S, Leo S, Lorusso V, De Lucia L, Roselli M. Comella P, et al. Ann Oncol. 2005 Jun;16(6):878-86. doi: 10.1093/annonc/mdi185. Epub 2005 Apr 18. Ann Oncol. 2005. PMID: 15837702 Free article. Clinical Trial.
Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study.
Comella P, Massidda B, Palmeri S, Farris A, Lucia LD, Natale D, Maiorino L, Tafuto S, Cataldis GD, Casaretti R. Comella P, et al. Cancer Chemother Pharmacol. 2005 Nov;56(5):481-6. doi: 10.1007/s00280-005-1003-6. Epub 2005 May 18. Cancer Chemother Pharmacol. 2005. PMID: 15902461 Clinical Trial.
140 results